156 related articles for article (PubMed ID: 23405077)
1. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.
Liu Y; Li L; Qi H; Gao Y; Liu S; Xu C
PLoS One; 2013; 8(2):e54081. PubMed ID: 23405077
[TBL] [Abstract][Full Text] [Related]
2. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
[TBL] [Abstract][Full Text] [Related]
3. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
Srivastava K; Srivastava A; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
[TBL] [Abstract][Full Text] [Related]
4. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y
Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581
[TBL] [Abstract][Full Text] [Related]
5. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.
Xu L; Zhou X; Xu L; Yin R
Tumour Biol; 2014 Feb; 35(2):1661-9. PubMed ID: 24096544
[TBL] [Abstract][Full Text] [Related]
6. Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis.
Mazoochi T; Karimian M; Ehteram H; Karimian A
Per Med; 2019 Jan; 16(1):67-78. PubMed ID: 30465472
[TBL] [Abstract][Full Text] [Related]
7. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
[TBL] [Abstract][Full Text] [Related]
8. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
[TBL] [Abstract][Full Text] [Related]
9. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
10. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population.
Yang L; Zhu H; Zhou B; Gu H; Yan H; Tang N; Dong H; Sun Q; Cong R; Chen G; Wang B
Dig Dis Sci; 2009 May; 54(5):1021-8. PubMed ID: 18716870
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α C1772T polymorphism and gastrointestinal tract cancer risk: a meta-analysis and meta-regression analysis.
Xu J; Xu L; Li L; You Q; Cha L
Genet Test Mol Biomarkers; 2013 Dec; 17(12):918-25. PubMed ID: 24063654
[TBL] [Abstract][Full Text] [Related]
12. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
13. Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis.
Zhou X; Lin C
World J Surg Oncol; 2015 Feb; 13():27. PubMed ID: 25889770
[TBL] [Abstract][Full Text] [Related]
14. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
[TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
Jaiswal PK; Goel A; Mandhani A; Mittal RD
Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
[TBL] [Abstract][Full Text] [Related]
16. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
17. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.
Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442
[TBL] [Abstract][Full Text] [Related]
18. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population.
Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J
J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759
[TBL] [Abstract][Full Text] [Related]
19. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
Moazeni-Roodi A; Ghavami S; Hashemi M
Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314
[TBL] [Abstract][Full Text] [Related]
20. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
